Back

Mitochondrial DNA integrity and antioxidant determinants of resilience to anthracycline-induced cardiotoxicity

31 August 2026 (14:03 - 14:15)
Organised by: Logo
Congress Presentation Part of: A deep dive into mechanisms underlying heart failure Cardiotoxicity of Drugs and Other Therapies ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Itamar Dias

University Medical Centre Groningen, Groningen (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Exploring the impact of age and comorbidities on quality-of-life improvements with empagliflozin: findings from a broad European real-world population
Professor A. Tomaszuk-Kazberuk (Bialystok, PL) Professor F. Malek (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Klotho regulates myocardial function in living human slices and cardiorenal phenotype in Klotho-deficient swine model
Ms I. Ornek (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Z-disc mechanosensory integrity dictates cardiac reverse remodeling: insights from multiscale imaging and gene-edited rat models
Mr H. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Non-canonical VEGFA N-terminal peptide functions as a nuclear regulator driving age-dependent cardiac remodelling
Doctor Z. Chen (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
A deep dive into mechanisms underlying heart failure
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 14:03 CET
You may be interested in
thumbnail
Congress Presentation
Mitochondrial dynamics and myocardial metabolism alterations during anthracycline-cardiotoxicity
22 May 2023
thumbnail
Congress Presentation
Myocardial DNA damage is responsible for the relationship between genotype and treatment response in patients with dilated cardiomyopathy
30 August 2024
thumbnail
Congress Presentation
Protective role of cardiac progenitor cell-derived-exosomes in a new human model of ageing-induced cardiac dysfunction
29 April 2022
thumbnail
Congress Presentation
Polydatin, a nutraceutical agent, reduces cardiotoxicity and enhances the anticancer effects of Sunitinib through the reduction of lipid peroxidation and expression of NLRP3 inflammasome
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources